Trials / Conditions / Essential Thrombocythaemia
Essential Thrombocythaemia
6 registered clinical trials studyying Essential Thrombocythaemia — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1 Study to Assess STP938 as a Monotherapy in Adults With High Risk Essential Thrombocythaemia NCT06786234 | Step Pharma, SAS | Phase 1 |
| Not Yet Recruiting | Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History NCT06923670 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients NCT06514807 | AOP Orphan Pharmaceuticals AG | Phase 3 |
| Completed | Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia NCT01230775 | AOP Orphan Pharmaceuticals AG | Phase 3 |
| Completed | The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) NCT00413634 | Shire | Phase 2 |
| Completed | Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia NCT01065038 | AOP Orphan Pharmaceuticals AG | Phase 3 |